Raltegravir labels and packages: Difference between revisions
(Created page with "__NOTOC__ {{Raltegravir}} {{CMG}}; {{AE}} {{chetan}} ==Labels and Packages==<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ISENTRESS (RALTEGRAVIR...") |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Labels and Packages== | ==Labels and Packages== | ||
PRINCIPAL DISPLAY PANEL - 400 mg Bottle Label | PRINCIPAL DISPLAY PANEL - 400 mg Bottle Label | ||
| Line 23: | Line 22: | ||
60 Tablets | 60 Tablets | ||
{| | {| | ||
| Line 29: | Line 30: | ||
|- | |- | ||
|} | |} | ||
| Line 48: | Line 50: | ||
60 Tablets | 60 Tablets | ||
{| | {| | ||
| Line 54: | Line 58: | ||
|- | |- | ||
|} | |} | ||
PRINCIPAL DISPLAY PANEL - 25 mg Bottle Label | PRINCIPAL DISPLAY PANEL - 25 mg Bottle Label | ||
| Line 71: | Line 77: | ||
Rx only | Rx only | ||
60 Tablets | 60 Tablets<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED ISENTRESS (RALTEGRAVIR) TABLET, CHEWABLE [MERCK SHARP & DOHME CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89a5ec53-d956-4329-8004-0f40f51c88a3 | publisher = | date = | accessdate = }}</ref> | ||
| Line 79: | Line 86: | ||
|- | |- | ||
|} | |} | ||
==References== | ==References== | ||
Latest revision as of 01:13, 10 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Labels and Packages
PRINCIPAL DISPLAY PANEL - 400 mg Bottle Label
NDC 0006-0227-61
Isentress® (raltegravir) tablets
400 mg
Each tablet contains 434.4 mg raltegravir potassium, equivalent to 400 mg raltegravir.
USUAL DOSAGE: See Package Insert.
Rx only
60 Tablets
| [[File:|800px|thumb]] |
PRINCIPAL DISPLAY PANEL - 100 mg Bottle Label
NDC 0006-0477-61
Isentress® (raltegravir) CHEWABLE Tablets
100 mg
For Pediatric Patients 2 to less than 12 Years of Age
Phenylketonurics: contains phenylalanine (a component of aspartame) 0.10 mg per 100 mg chewable tablet.
Rx only
60 Tablets
| [[File:|800px|thumb]] |
PRINCIPAL DISPLAY PANEL - 25 mg Bottle Label
NDC 0006-0473-61
Isentress® (raltegravir) CHEWABLE Tablets
25 mg
For Pediatric Patients 2 to less than 12 Years of Age
Phenylketonurics: contains phenylalanine (a component of aspartame) 0.05 mg per 25 mg chewable tablet.
Rx only
60 Tablets[1]
| [[File:|800px|thumb]] |
References
Adapted from the FDA Package Insert.